IPO - PowerUp Acquisition Corp.

Form Type: S-1

Filing Date: 2025-04-09

Corporate Action: Ipo

Type: New

Accession Number: 000164117225003291

Filing Summary: Aspire Biopharma Holdings, Inc. submitted its registration statement on Form S-1 for an initial public offering (IPO) with the SEC on April 9, 2025. The filing indicates that the company will offer a total of up to 3,150,554 shares of common stock, which includes 2,213,054 shares previously issued as commitment shares and an additional 937,500 shares reserved for issuance upon conversion of its Convertible Debenture. The IPO follows the consummation of a Business Combination on February 17, 2025, with Aspire Biopharma, Inc., indicating a significant corporate restructuring and the transition to a public entity. The shares are set to be traded under the ticker symbol 'ASBP' on the Nasdaq Global Market. The company intends to bear the costs associated with the registration of these shares, while any capital raised will be attributed to the selling shareholders. The prospectus highlights potential risks and market data related to Aspire’s business and prospects, further asserting that it is not soliciting offers to buy securities where not permitted by law.

Document Link: View Document